Environmental exposure to common pesticides may cause boys to reach sexual maturity earlier, researchers have found. They will present their study results Saturday at the Endocrine Society’s 99th annual meeting in Orlando, Fla.
Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday at the Endocrine Society’s 99th annual meeting, ENDO 2017, in Orlando, Fla.
Exposure during infancy to the common plasticizer bisphenol A (BPA) “hijacks” and reprograms genes in the liver of newborn rats, leading to nonalcoholic fatty liver disease (NAFLD) in adulthood. A new study has found how this process occurs, and researchers will present the results Saturday at ENDO 2017, the Endocrine Society’s 99th annual meeting in Orlando, Fla.
Preventive medicine experts at Rush University Medical Center have discovered that delaying access to tempting, high-calorie foods and snacks in vending machines potentially can shift people’s choices to purchase less desired, but healthier snack options.
The Endocrine Society is proudly partnering with the March for Science, which will bring together more than 100 scientific organizations on Saturday, April 22 to celebrate science and rally public support for publicly funded research.
Cutting-edge multidisciplinary research from across the life sciences will be presented at the Experimental Biology 2017 meeting (EB 2017), the premier annual meeting of six scientific societies in Chicago to be held April 22–26.
Ludwig Cancer Research released today the full scope of advances to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Washington D.C., April 1-5, 2017.
Scientists from the Fred Hutchinson Cancer Research Center in Seattle are scheduled to present and discuss the latest developments in immunotherapy and proteomics at the American Association for Cancer Research Annual Meeting, Research Propelling Cancer Prevention and Cures, on April 1-5. What follows is a selection of the more than 30 Hutch presentations at the AACR gathering
From using fluid in the lungs to better understand the potential of immunotherapy treatments in lung cancer, to tracking circulating tumor cells in prostate cancer, to conducting RNA sequencing of cancer cell clusters from the blood of pancreatic cancer patients, to finding new ways to biopsy tissue from patients who may have esophageal cancer, a series of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate the promise of new diagnostic methods.
Judy E. Garber, MD, MPH, director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, has been honored by the American Association for Cancer Research (AACR) for outstanding achievement in clinical cancer research.
News conferences will explore the latest research advances in obesity and diabetes technologies, thyroid conditions, men’s health and endocrine-disrupting chemicals at ENDO 2017, the Endocrine Society’s 99th Annual Meeting & Expo. The meeting will take place April 1–4 in Orlando, Fla.
The American Pain Society (APS), www.americanpainsociety.org, will host its 36th Annual Scientific Meeting May 17-20 at the Pittsburgh Convention Center. APS is the leading multidisciplinary professional society in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics and blacks had a higher burden of poor health-related quality-of-life (HR-QoL) than white patients and that poor HR-QoL resulted in shorter median survival. Yet Hispanics had an average survival time of 85.4 months as compared to blacks at 47.8 months and whites at 43.2 months.
Building on their previous research focusing on vaccination within a tumor (intratumoral) for the most common form of pancreatic cancer, investigators from Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School have shown that in a mouse model of early stage resected pancreatic cancer, intratumoral vaccination induces an anti-tumor response that results in a significant improvement in overall survival.
Ablation procedures restore a regular heartbeat in patients who have a dangerous, abnormal heart rhythm called atrial fibrillation. But it doesn’t always work. Now, a new study suggests that certain molecules are associated with the recurrence of erratic heartbeats in some patients after ablation therapy.
Study investigates whether modern statin guidelines accurately identify African American patients with atherosclerotic cardiovascular disease.
A typical intervention for PE patients includes anticoagulants in an effort to prevent migration of the blood clot, but the higher-risk PE population – about 30 percent of all PE patients – are potential candidates for catheter-directed thrombolysis (CDT) and systemic thrombolysis (ST), both of which employ “clot-busting” medications known as tissue plasminogen activator (tPA). However, in a new study presented today at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that the utilization rates of these potentially life-saving medications are low, particularly in the sub-group of PE patients who are critically ill.
Professional baseball players struggle to return to a high level of play after biceps tenodesis (BP) surgery, according to research presented today at the American Orthopaedic Society for Sports Medicine’s (AOSSM) Specialty Day in San Diego. The study examined how players with SLAP tears responded to biceps tenodesis.
Age, gender and frequency of physical therapy utilization after an Anterior Cruciate Ligament (ACL) surgery may be correlated with second ACL reconstruction rates, according to researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s Specialty Day today.
Research presented at the American Orthopaedic Society for Sports Medicine’s (AOSSM) Specialty Day in San Diego shows arthroscopic superior capsule reconstruction (SCR), a surgical approach to treat irreparable rotator cuff tears, may eliminate pseudoparalysis and significantly improve shoulder function.
Consistently using a tackling education program appears to help lessen youth football concussion severity and occurrence, say researchers presenting their work today at the American Orthopaedic Society for Sports Medicine’s Specialty Day in San Diego, CA.
A majority of Anterior Cruciate Ligament (ACL) reconstruction patients develop a condition known as posttraumatic osteoarthritis (PTOA) within 15 years of surgery, which can be debilitating and limit activity. Researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s (AOSSM) Specialty Day in San Diego are highlighting how a set of biomarkers on the day of surgery may explain why some individuals have worse PTOA than others after two years.
Patients with hypertrophic cardiomyopathy are urged to take it easy. But new research shows they might benefit from moderate aerobic exercise.
For patients with persistent AF or those who are at high risk for recurring AF, catheter ablation – a minimally invasive procedure in which the areas of the heart causing the irregularity are cauterized – is recommended, followed most often by continued use of blood thinners, regardless of whether the ablation procedure was effective. In new study presented today at the American College of Cardiology Annual Scientific Sessions, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that patients with persistent AF, who are successfully treated with ablation many, in fact, no longer need blood thinners.
Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial, which was presented at the American College of Cardiology (ACC) 66th Annual Scientific Session and published simultaneously in The New England Journal of Medicine (NEJM) (1).
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City finds that combining information from routine blood tests and age of primary care patients can create a score that measures future risk of chronic disease.
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Collaborative study with Cleveland Clinic & SUNY Upstate Medical University shows that single high-dose SBRT treatment is as effective as three doses in patients with non-small cell lung cancer
An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors (ICPIs) to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects.
Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to research presented today at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging methods found evidence of recurrence.
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment.
The genetic mutations underlying treatment resistance in non-small cell lung cancer (NSCLC) are more complex and dynamic than previously thought.
Treating the brain with a preventative course of radiation may help Small Cell Lung Cancer (SCLC) patients – whose tumors often spread to their brain -- live longer, according to a new study from researchers in the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania. A separate study revealed that the most commonly-targeted mutation of Non-Small Cell Lung Cancer (NSCLC) is most likely to result in progression at the primary site.
New Michigan State University research has found that refugees diagnosed with post-traumatic stress disorder regulate stress differently than those who don’t have the disorder, but may have experienced similar suffering.
Bone morphogenetic proteins, commonly used off-label to enhance pediatric spinal fusion, did not improve revision rates for pediatric spinal fusion, according to a study by researchers at Hospital for Special Surgery.
Depression is the strongest predictor of death in the first decade following a diagnosis of coronary heart disease, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Middle-aged people who experience temporary blood pressure drops that often cause dizziness upon standing up may be at an increased risk of developing cognitive decline and dementia 20 years later, new Johns Hopkins Bloomberg School of Public Health research suggests.
ISPOR announced plenary sessions and speakers for its 22nd Annual International Meeting that will be held May 20-24, 2017 in Boston, MA, USA. The conference will focus on significant changes in health care and policy with the timely theme, "Evidence and Value in a Time of Social and Policy Change."
When it comes to skin care product labels, people shouldn’t necessarily believe everything they read.
It's important for Latino patients to understand their skin cancer risk, take steps to protect themselves and conduct regular skin self-exams.
On average, one person dies of melanoma, the deadliest form of skin cancer, every hour. Because this disease can affect anyone, everyone should take steps to reduce their risk and catch melanoma in its earliest stages, when it’s most treatable.
While poison ivy is probably the most well-known hazardous plant, there are a multitude of other plants, as well as many insects, that can irritate your skin.
While some individuals may believe tanning makes them more beautiful, this habit can actually damage their skin in the long run. Ultraviolet radiation from the sun and indoor tanning beds can not only increase one’s skin cancer risk but...
Alopecia areata, atopic dermatitis and vitiligo are highly visible dermatologic conditions that can have a negative effect on patients’ quality of life and overall health. An emerging treatment option, however, could provide effective therapy...
Dr. Kerin Adelson discusses the in-house specialty pharmacy at Smilow Cancer Hospital with HemeOnc Today
Since 2012, research teams in the Qualcomm Tricorder Xprize competition have vied to create a mobile diagnostic device modeled after the fictional medical tricorder from Star Trek. For the first time, competition finalist Chung-Kang Peng, PhD, will present data on his team’s tricorder prototype in a special session at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.
Northwestern University biomedical engineers have developed imaging technology that is the first to see DNA “blink,” or fluoresce. The tool enables researchers to study individual biomolecules (DNA, chromatin, proteins) as well as important global patterns of gene expression, which could yield insights into cancer. Vadim Backman will discuss the technology and its applications -- including the new concept of macrogenomics, a technology aiming to regulate the global patterns of gene expression without gene editing -- at the 2017 AAAS annual meeting.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right